ASPIRIN DL-LYSINE: 6,636 Adverse Event Reports & Safety Profile
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
6,636
Total FAERS Reports
1,107 (16.7%)
Deaths Reported
3,761
Hospitalizations
6,636
As Primary/Secondary Suspect
788
Life-Threatening
158
Disabilities
First Report: 19980213 · Latest Report: 20250906
What Are the Most Common ASPIRIN DL-LYSINE Side Effects?
#1 Most Reported
Acute kidney injury
658 reports (9.9%)
#2 Most Reported
Anaemia
469 reports (7.1%)
#3 Most Reported
Lactic acidosis
312 reports (4.7%)
All ASPIRIN DL-LYSINE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Acute kidney injury | 658 | 9.9% | 146 | 271 |
| Anaemia | 469 | 7.1% | 34 | 356 |
| Lactic acidosis | 312 | 4.7% | 113 | 30 |
| Hyperkalaemia | 246 | 3.7% | 46 | 65 |
| Interstitial lung disease | 225 | 3.4% | 25 | 153 |
| Cerebral haemorrhage | 219 | 3.3% | 100 | 89 |
| Fall | 218 | 3.3% | 79 | 140 |
| Melaena | 200 | 3.0% | 31 | 152 |
| Thrombocytopenia | 189 | 2.9% | 2 | 118 |
| Diarrhoea | 180 | 2.7% | 14 | 82 |
| Eosinophilia | 173 | 2.6% | 7 | 134 |
| Cholestasis | 144 | 2.2% | 15 | 67 |
| Rectal haemorrhage | 144 | 2.2% | 21 | 110 |
| Off label use | 137 | 2.1% | 48 | 87 |
| Subdural haematoma | 132 | 2.0% | 55 | 73 |
| Hypotension | 125 | 1.9% | 10 | 74 |
| Ischaemic stroke | 125 | 1.9% | 32 | 92 |
| Pruritus | 123 | 1.9% | 1 | 79 |
| Shock haemorrhagic | 121 | 1.8% | 63 | 31 |
| Cerebral haematoma | 114 | 1.7% | 46 | 72 |
Who Reports ASPIRIN DL-LYSINE Side Effects? Age & Gender Data
Gender: 39.6% female, 60.4% male. Average age: 71.6 years. Most reports from: FR. View detailed demographics →
Is ASPIRIN DL-LYSINE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2003 | 7 | 0 | 7 |
| 2004 | 3 | 0 | 3 |
| 2005 | 3 | 2 | 3 |
| 2006 | 12 | 1 | 10 |
| 2007 | 14 | 11 | 6 |
| 2008 | 2 | 0 | 2 |
| 2009 | 23 | 8 | 16 |
| 2010 | 29 | 0 | 26 |
| 2011 | 35 | 9 | 19 |
| 2012 | 45 | 10 | 34 |
| 2013 | 21 | 2 | 14 |
| 2014 | 62 | 6 | 36 |
| 2015 | 135 | 27 | 72 |
| 2016 | 243 | 28 | 176 |
| 2017 | 561 | 69 | 326 |
| 2018 | 1,086 | 213 | 655 |
| 2019 | 1,021 | 174 | 569 |
| 2020 | 821 | 143 | 470 |
| 2021 | 654 | 124 | 296 |
| 2022 | 499 | 73 | 302 |
| 2023 | 511 | 56 | 272 |
| 2024 | 391 | 78 | 185 |
| 2025 | 166 | 14 | 114 |
What Is ASPIRIN DL-LYSINE Used For?
| Indication | Reports |
|---|---|
| Product used for unknown indication | 1,642 |
| Prophylaxis | 705 |
| Cardiovascular event prophylaxis | 653 |
| Thrombosis prophylaxis | 468 |
| Myocardial ischaemia | 445 |
| Myocardial infarction | 186 |
| Cerebrovascular accident | 141 |
| Atrial fibrillation | 134 |
| Acute coronary syndrome | 117 |
| Ischaemic stroke | 99 |
ASPIRIN DL-LYSINE vs Alternatives: Which Is Safer?
ASPIRIN DL-LYSINE vs ASPIRIN LYSINE
ASPIRIN DL-LYSINE vs ASPIRIN\BUTALBITAL\CAFFEINE
ASPIRIN DL-LYSINE vs ASPIRIN\CAFFEINE
ASPIRIN DL-LYSINE vs ASPIRIN\CARISOPRODOL
ASPIRIN DL-LYSINE vs ASPIRIN\CARISOPRODOL\CODEINE
ASPIRIN DL-LYSINE vs ASPIRIN\CLOPIDOGREL
ASPIRIN DL-LYSINE vs ASPIRIN\CLOPIDOGREL BISULFATE
ASPIRIN DL-LYSINE vs ASPIRIN\DIPYRIDAMOLE
ASPIRIN DL-LYSINE vs ASPIRIN\LANSOPRAZOLE
ASPIRIN DL-LYSINE vs ASPIRIN\MAGNESIUM
Official FDA Label for ASPIRIN DL-LYSINE
Official prescribing information from the FDA-approved drug label.